pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
LEADING · news · pharmadog
← back to LEADING
News mentioning LEADING
209
stories
22d
New York boys club has a time-tested recipe to protect members’ mental health
stat
22d
GSK ends brain drug alliance with Alector
biopharma dive
23d
AstraZeneca, Ionis drug fails big heart disease study in major setback
biopharma dive
23d
Who’s going to run the FDA?
stat
23d
Opinion: Your grandparents are using cannabis. Doctors can help them do it safely
stat
23d
Opinion: Who benefits from classifying obesity as a disease?
stat
23d
Transplants extended survival for patients whose stage 4 lung cancer hadn’t spread, study says
stat
23d
Prime wins gene editing dispute; Saol claims latest post-Makary FDA reversal
biopharma dive
24d
Opinion: The AI licensure debate is missing the point of licensure
stat
24d
Are glucose monitors a good thing for 2-year-olds? Experts look at risks, benefits
stat
24d
Vertex to acquire Crinetics in $10B foray into endocrine disease drugs
biopharma dive
25d
Novartis to acquire ADC developer in a deal worth up to $1.5B
biopharma dive
29d
Roche KRAS drug succeeds in head-to-head lung cancer study
biopharma dive
Jul 2, 26
Opinion: CDC leadership continues to try to manufacture a scientific debate on vaccines where none exists
stat
Jul 2, 26
STAT+: A year after distressed buyout, what’s become of Bluebird Bio?
stat
Jul 2, 26
The new presidential fitness test is a positive step, not the solution, experts say
stat
Jul 1, 26
Statins and blood pressure drugs changing health risks of obesity, study suggests
stat
Jun 30, 26
These biotechs just landed big fundraising hauls. Here’s what they pitched to investors.
biopharma dive
Jun 30, 26
Opinion: Florida is the first state to require EKGs for high school athletes. It’s a mistake
stat
Jun 29, 26
10 clinical trials to watch in the second half of 2026
biopharma dive
Jun 26, 26
FDA accepts Replimune filing; Merck KGaA drops $11B on life sciences services
biopharma dive
Jun 26, 26
Alkermes’ incoming CEO has a plan to outplay Lilly and Takeda
biopharma dive
Jun 20, 26
Opinion: STAT readers debate blue zones, open-access publishing fees, and more
stat
Jun 18, 26
STAT+: Pharmalittle: We’re reading about an FDA review of Moderna’s flu shot, J&J’s focus on cancer, and more
stat
Jun 18, 26
Opinion: Congress should embrace strategic health diplomacy
stat
Jun 18, 26
Opinion: AI’s growing appetite for power is a public health issue. Here’s a fix
stat
Jun 17, 26
UniQure to file gene therapy for approval, reflecting major shifts at FDA
biopharma dive
Jun 16, 26
STAT+: ARCH-launched Neumora stops depression program
stat
Jun 15, 26
Takeda fortifies orexin potential with more Phase 3 data
endpoints
Jun 15, 26
Covid vaccination cut risk of adverse heart events, large study finds
stat
← prev
page 4 of 7
next →
